


国际肿瘤学杂志››2014,Vol. 41››Issue (12): 893-895.doi:10.3760/cma.j.issn.1673-422X.2014.12.005
出版日期:2014-12-24发布日期:2015-02-02通讯作者:周逢海,Email: zhoufengh@163.com
Online:2014-12-24Published:2015-02-02Contact:Zhou Fenghai, Email: zhoufengh@163.com摘要:肿瘤组织中存在的肿瘤干细胞是肿瘤转移和复发的根源,而转化生长因子β1(TGFβ1)在肿瘤干细胞的增殖分化过程中有着重要的调节作用,目前在许多肿瘤包括乳腺癌、肝癌、胰腺癌、肺癌、胶质瘤、胆囊癌等的肿瘤组织中发现,TGFβ1诱导的上皮间质转化(EMT)能够抑制肿瘤细胞增殖,同时富集肿瘤干细胞,增加肿瘤的侵袭和耐药能力。
马玉磊, 李海元, 周川, 周逢海, 吕海迪, 王施广. 转化生长因子-β1在肿瘤干细胞中的作用[J]. 国际肿瘤学杂志, 2014, 41(12): 893-895.
MA Yu-Lei, LI Hai-Yuan, ZHOU Chuan, ZHOU Feng-Hai,LV Hai-Di , WANG Shi-Guang. Roles of transforming growth factor-β1 in cancer stem cells[J]. Journal of International Oncology, 2014, 41(12): 893-895.
| [1] BarcellosHoff MH, Akhurst RJ. Transforming growth factorbeta in breast cancer: too much, too late[J]. Breast Cancer Res, 2009, 11(1): 202. [2] Watabe T, Miyazono K. Roles of TGFβ family signaling in stem cell renewal and differentiation[J]. Cell Res, 2009, 19(1): 103115. [3] He XC, Zhang J, Tong W, et al. BMP signaling inhibits intestinal stem cell selfrenewal through suppression of Wntβcatenin signaling[J]. Nat Genet, 2004, 36(10): 11171121. [4] Kobielak K, Stokes N, de la Cruz J, et al. Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling[J]. Proc Nat Acad Sci USA, 2007, 104(24): 1006310068. [5] Jian H, Shen X, Liu L, et al. Smad3dependent nuclear translocation of betacatenin is required for TGFbeta1induced proliferation of bone marrowderived adult human mesenchymal stem cell[J]. Genes Dev, 2006, 20(6): 666674. [6] Falk S, Wurdak H, Ittner LM, et al. Brain areaspecific effect of TGFβ signaling on Wntdependent neural stem cell expansion[J]. Cell Stem Cell, 2008, 2(5): 472483. [7] AlHajj M, Wicha MS, BenitoHernandez A, et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Nat Acad Sci, 2003, 100(7): 39833988. [8] Marx J. Mutant stem cells may seed cancer[J]. Science, 2003, 301(5638): 13081310. [9] Rasheed ZA, Kowalski J, Smith BD, et al. Concise review: emerging concepts in clinical targeting of cancer stem cells[J]. Stem Cells, 2011, 29(6): 883887. [10] Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts[J]. Annu Rev Med, 2007, 58: 267284. [11] Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cellsperspectives on current status and future directions: AACR Workshop on cancer stem cells[J]. Cancer Res, 2006, 66(19): 93399344. [12] Rubio D, GarciaCastro J, Martín MC, et al. Spontaneous human adult stem cell transformation[J]. Cancer Res, 2005, 65(8): 30353039. [13] Cozzio A, Passegué E, Ayton PM, et al. Similar MLLassociated leukemias arising from selfrenewing stem cells and shortlived myeloid progenitors[J]. Genes Dev, 2003, 17(24): 30293035. [14] Taylor MA, Lee YH, Schiemann WP, et al. Role of TGFβ and the tumor microenvironment during mammary tumorigenesis[J]. Gene Expr, 2011, 15(3): 117132. [15] Qiu LX, Yao L, Mao C, et al. TGFβ1 L10p polymorphism is associated with breast cancer susceptibility: evidence from a metaanalysis involving 47817 subjects[J]. Breast Cancer Res Treat, 2010, 123(2): 563567. [16] Asiedu MK, Ingle JN, Behrens MD, et al. TGF beta/TNF(alpha)mediated epithelialmesenchymal transition generates breast cancer stem cells with a claudinlow phenotype[J]. Cancer Res, 2011, 71(13): 47074719. [17] 沈娜. TGFβ1对乳腺癌细胞及乳腺癌干细胞特征作用的研究[D]. 武汉: 华中科技大学, 2012. [18] Coyle B, Freathy C, Gant TW, et al. characterization of the transforming growth factorbeta1 induced apoptotic transcriptome in FaO hepatoma cell[J]. Biol Chem, 2003, 278(8): 59205928. [19] Song BC, Chung YH, Kim JA, et al. Transforming growth factorβ1 as a useful serologic marker of small hepatocellular carcinoma[J]. Cancer, 2002, 94(1): 175180. [20] 史壹雄. 转化生长因子β1诱导胰腺癌肿瘤干细胞产生的研究[D]. 杭州: 浙江大学, 2011. [21] 高全立, 汪萍, Kvalheim G, 等. TGFβ1对肺癌干细胞和非干细胞增殖的影响[J]. 中国肿瘤生物治疗杂志, 2010, 17(4): 24162421. [22] You H, Ding W, Rountree CB. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factorbeta[J]. Hepatology, 2010, 51(5): 16351644. [23] 刘兰兰, 杨兆娟, 邹飞雁, 等. 转化生长因子β1对肝癌细胞干性表型的调节作用[J]. 肿瘤, 2012, 32(4): 227233. [24] Peuelas S, Anido J, PrietoSánchez RM, et al. TGFβ increases gliomainitiating cell selfrenewal through the induction of LIF in human glioblastoma[J]. Cancer Cell, 2009, 15(4): 315327. [25] 曹响元, 赵耀东, 楼美清. TGFβ信号通路与胶质细胞瘤生物学行为的关系[J]. 中国神经肿瘤杂志, 2013, 10(1): 5157. [26] Anido J, SaezBorderias A, GonzalezJunca A, et al. TGFβ receptor inhibitors target the CD44(high) gliomainitiating cell population in human gliblastoma[J]. Cancer Cell, 2010, 18(6): 655668. [27] Qiu B, Zhang D, Wang C, et al. IL10 and TGFβ2 are overexpressed in tumor spheres cultured from human gliomas[J]. Mol Bio Rep, 2011, 38(5): 35853591. [28] Ikushima H, Todo T, Ino Y, et al. Autocrine TGFβ signaling maintains tumorigenicity of gliomainitiating cells through Sryrelated HMGbox factors[J]. Cell Stem Cell, 2009, 5(5): 504514. [29] 张志发. 人胆囊癌SP细胞的分选、鉴定及TGFβ对其丰度的影响和机制的研究[D]. 武汉: 华中科技大学, 2011. |
| [1] | 刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325. |
| [2] | 袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343. |
| [3] | 许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363. |
| [4] | 王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384. |
| [5] | 王昆, 周中新, 臧其威.血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203. |
| [6] | 钟楠, 王淡瑜, 周欢欢, 刘宁, 戴纬, 刘黎琼, 郭智.CD30单抗联合PD-1抑制剂治疗复发难治性霍奇金淋巴瘤的疗效与安全性[J]. 国际肿瘤学杂志, 2024, 51(4): 245-248. |
| [7] | 滕远, 李莉娟, 张连生.MCL-1及其抑制剂在血液恶性肿瘤中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 119-122. |
| [8] | 李丹, 李睿尧, 李膺函, 于秀艳, 吴雪峰.血清miR-19b、miR-744-5p水平在非小细胞肺癌诊断中的临床价值[J]. 国际肿瘤学杂志, 2024, 51(2): 83-88. |
| [9] | 冯东旭, 吴炜, 高平发, 王军, 施丽娟, 陈大伟, 李文兵, 张美峰.miR-451通过调控Rho/ROCK1信号通路对乳腺癌细胞糖酵解及凋亡的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 449-456. |
| [10] | 潘书兰, 刘畅, 贺平.福瑞替尼对三阴性乳腺癌血管生成、肿瘤生长及IRE1-ASK1-JNK通路的影响[J]. 国际肿瘤学杂志, 2023, 50(8): 457-462. |
| [11] | 邵慧芳, 王学红, 芦永福.CST1在胃癌进展中的作用机制及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 489-492. |
| [12] | 徐凡, 王婧, 毛宁, 王世雄, 李金茂.戈沙妥珠单抗治疗晚期三阴性乳腺癌1例[J]. 国际肿瘤学杂志, 2023, 50(8): 508-510. |
| [13] | 李金歌, 李晶, 张振悍, 郭建鑫, 王景普, 吴忠冰.4-硝基喹啉-1-氧化物诱导小鼠食管鳞状细胞癌模型的研究进展[J]. 国际肿瘤学杂志, 2023, 50(7): 437-441. |
| [14] | 陈卓, 陶俊, 陈琳, 柯晶.外周血miR-194联合粪便miR-143检测对结直肠癌临床筛查的价值[J]. 国际肿瘤学杂志, 2023, 50(5): 268-273. |
| [15] | 拜莹, 李琦, 李亚芹, 赵卫红.E2F1与lncRNA在恶性肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2023, 50(3): 164-168. |
| 阅读次数 | ||||||
| 全文 |
|
|||||
| 摘要 |
|
|||||